Literature DB >> 23863467

Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity.

Wenpeng Cui1, Hasiyeti Maimaitiyiming, Xinyu Qi, Heather Norman, Shuxia Wang.   

Abstract

Obesity is prevalent worldwide and is a major risk factor for many diseases including renal complications. Thrombospondin 1 (TSP1), a multifunctional extracellular matrix protein, plays an important role in diabetic kidney diseases. However, whether TSP1 plays a role in obesity-related kidney disease is unknown. In the present studies, the role of TSP1 in obesity-induced renal dysfunction was determined by using a diet-induced obese mouse model. The results demonstrated that TSP1 was significantly upregulated in the kidney from obese mice. The increased TSP1 was localized in the glomerular mesangium as well as in the tubular system from obese wild-type mice. Obese wild-type mice developed renal hypertrophy and albuminuria, which was associated with increased kidney macrophage infiltration, augmented kidney inflammation, and activated transforming growth factor (TGF)-β signaling and renal fibrosis. In contrast, obese TSP1-deficient mice did not develop these kidney damages. Furthermore, in vitro studies demonstrated that leptin treatment stimulated the expression of TSP1, TGF-β1, fibronectin, and collagen type IV in mesangial cells isolated from wild-type mice. These leptin-stimulated effects were abolished in TSP1-deficient mesangial cells. Taken together, these data suggest that TSP1 is an important mediator for obesity- or hyperleptinemia-induced kidney dysfunction.

Entities:  

Keywords:  kidney; leptin; obesity; thrombospondin 1

Mesh:

Substances:

Year:  2013        PMID: 23863467      PMCID: PMC3761287          DOI: 10.1152/ajprenal.00209.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  56 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose.

Authors:  Natalia Yevdokimova; Nadia Abdel Wahab; Roger M Mason
Journal:  J Am Soc Nephrol       Date:  2001-04       Impact factor: 10.121

Review 4.  Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.

Authors:  J E Murphy-Ullrich; M Poczatek
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

5.  Functional and structural changes in the kidney in the early stages of obesity.

Authors:  Jeffrey R Henegar; Steven A Bigler; Lisa K Henegar; Suresh C Tyagi; John E Hall
Journal:  J Am Soc Nephrol       Date:  2001-06       Impact factor: 10.121

6.  Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity.

Authors:  Li-Jun Ma; Bridgette A Corsa; Jun Zhou; HaiChun Yang; HaiJing Li; Yi-Wei Tang; Vladimir R Babaev; Amy S Major; MacRae F Linton; Sergio Fazio; Tracy E Hunley; Valentina Kon; Agnes B Fogo
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-02

Review 7.  Obesity-hypertension: the effects on cardiovascular and renal systems.

Authors:  R Zhang; E Reisin
Journal:  Am J Hypertens       Date:  2000-12       Impact factor: 2.689

8.  Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells.

Authors:  Shuxia Wang; Sruti Shiva; Maria H Poczatek; Victor Darley-Usmar; Joanne E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2002-01-09       Impact factor: 5.157

9.  Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression.

Authors:  D C Han; M Isono; S Chen; A Casaretto; S W Hong; G Wolf; F N Ziyadeh
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

10.  Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects.

Authors:  J M Ramis; N L W Franssen-van Hal; E Kramer; I Llado; F Bouillaud; A Palou; J Keijer
Journal:  Cell Mol Life Sci       Date:  2002-11       Impact factor: 9.261

View more
  24 in total

1.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 2.  Immunologic and endocrine functions of adipose tissue: implications for kidney disease.

Authors:  Qingzhang Zhu; Philipp E Scherer
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

3.  [Impacts of periodontitis on visceral organ weight and weight percentage in obese mice].

Authors:  Ting Yu; Li Zhao; Jin-Cai Zhang; Dong-Ying Xuan
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-10-01

Review 4.  Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.

Authors:  Joanne E Murphy-Ullrich; Mark J Suto
Journal:  Matrix Biol       Date:  2017-12-27       Impact factor: 11.583

5.  Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Qi Zhou; Heather Norman; Changcheng Zhou; Shuxia Wang
Journal:  Biochim Biophys Acta       Date:  2015-03-31

6.  Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Xinyu Qi; Heather Norman; Qi Zhou; Xiaojun Wang; Jian Fu; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

Review 7.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

8.  Association of Plasma Thrombospondin-1 Level with Cardiovascular Disease and Mortality in Hemodialysis Patients.

Authors:  Chi-Lun Huang; Yuh-Shiun Jong; Yen-Wen Wu; Wei-Jie Wang; Ai-Ru Hsieh; Chia-Lun Chao; Wen-Jone Chen; Wei-Shiung Yang
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

9.  Blockade of Orai1 Store-Operated Calcium Entry Protects against Renal Fibrosis.

Authors:  Xiaoyi Mai; Jinyan Shang; Sijia Liang; Beixin Yu; Jiani Yuan; Yu Lin; Renfei Luo; Feiran Zhang; Yingying Liu; Xiaofei Lv; Chunling Li; Xinling Liang; Weidong Wang; Jiaguo Zhou
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

Review 10.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.